Back
SpringWorks Therapeutics 10K Form
Sell
22
SWTX
SpringWorks Therapeutics
Last Price:
38.69
Seasonality Move:
12.83%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive SWTX News And Ratings
See the #1 stock for the next 7 days that we like better than SWTX
SWTX Financial Statistics
Sales & Book Value
Annual Sales: | $5.45M |
---|---|
Cash Flow: | $-54.02M |
Price / Cash Flow: | 0 |
Annual Sales: | $7.50 |
Price / Book: | 5.16 |
Profitability
EPS (TTM): | -4.44000 |
---|---|
Net Income (TTM): | $-301.06M |
Gross Margin: | $5.03M |
Return on Equity: | -57.97% |
Return on Assets: | -50.43% |
SpringWorks Therapeutics Earnings Forecast
Key SpringWorks Therapeutics Financial Ratios
- The Gross Profit Margin over the past 3 years for SWTX is 92.25%.
- The Selling, General & Administrative Expenses for SWTX have been equal to 3,626.79% of Gross Profit Margin.
- The Research & Development expenses have been 2,762.75% of Revenue.
- The Net Earning history of SWTX is -5,968.50% of Total Revenues.
- Per Share Earnings over the last 6 years have been positive in 2 years.
SpringWorks Therapeutics Stock Price Chart
Industry, Sector and Symbol
Stock Exchange: | NASDAQ |
---|---|
Industry: | Biotechnology |
Sector: | Health Care |
Current Symbol: | SWTX |
CUSIP: | 85205L |
Website: | springworkstx.com |
Debt
Debt-to-Equity Ratio: | 0 |
---|---|
Current Ratio: | 7.91 |
Quick Ratio: | 7.49 |
Price-to-Earnings
Trailing P/E Ratio: | 0 |
---|---|
Forward P/E Ratio: | 0 |
SWTX Technical Analysis vs Fundamental Analysis
Sell
22
SpringWorks Therapeutics (SWTX)
is a Sell
Is SpringWorks Therapeutics a Buy or a Sell?
-
SpringWorks Therapeutics stock is rated a Sell
The current SpringWorks Therapeutics [SWTX] share price is $38.70. The Score for SWTX is 22, which is 56% below its historic median score of 50, and infers higher risk than normal.